Thus, RUVBL2 may contribute to tumorigenesis and cancer development; indeed, RUVBL2 overexpression has been reported in HCC, colorectal cancer, renal cell carcinoma, gastric cancer, breast cancer and salivary gland cancer [11, 16–20]. The gene discussed is RUVBL2; the disease is breast cancer.